Clay Thorp - 22 Jun 2023 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
22 Jun 2023
Net transactions value
$0
Form type
4
Filing time
23 Jun 2023, 16:41:43 UTC
Previous filing
19 May 2023
Next filing
25 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Stock Option (right to buy) Award $0 +30,000 $0.000000 30,000 22 Jun 2023 Common Stock 30,000 $1.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2024, subject to the Reporting Person's continuous service as of such vesting date.